Robert H. Baron is a partner in Cravath’s Litigation Department and serves as the department’s Managing Partner. He has handled major commercial cases brought as individual and class actions in the Federal and state courts, including the representation of major domestic and foreign issuers and financial institutions in litigation related to securities offerings and trading, complex structured financing transactions and mergers and acquisitions.
Mr. Baron’s representative cases include:
- Defense of JPMorgan Chase & Co. and related entities in residential mortgage‑backed securities litigation filed in Federal and state courts across the country;
- Defense of Merck & Co., Inc., in Federal securities, derivative and ERISA class action litigation arising out of the September 2004 withdrawal of VIOXX®;
- Defense of Deutsche Bank AG and Credit Suisse in contract and tort actions arising out of the failed merger of Hexion and Huntsman, including Hexion’s claims in New York court for specific performance of $15.4 billion of financing commitments and Huntsman’s tort claims in Texas court for $4.65 billion in compensatory damages;
- Defense of Goldman Sachs against multibillion‑dollar fraudulent conveyance claims asserted by the Unsecured Creditors Committee in the Lyondell bankruptcy proceeding;
- Defense of Deutsche Telekom AG in a Federal securities class action arising out of the company’s June 2000 €13 billion equity offering and $33 billion acquisition of VoiceStream Wireless announced in July 2000;
- Defense of Arch Chemicals, Inc., Burlington Northern Santa Fe Corp., Casey’s General Stores, Inc., Gerber Scientific, Inc., Stanley, Inc., Qualcomm Incorporated, Novartis AG, Linde AG and Polymer Group, Inc. in litigation relating to announced or proposed merger and acquisition transactions involving each of those companies;
- Defense of HCA Inc. and its directors in shareholder class actions in Tennessee and Delaware challenging the $33 billion leveraged buyout of HCA in 2006 by a consortium of private equity firms (preliminary injunctions denied);
- Representation of the former CEO of a major European company in connection with FCPA investigations by the SEC and DOJ;
- Defense of former senior executives of Levitz Home Furnishings, Inc., in a Federal securities fraud action brought by purchasers of high‑yield bonds sold by Levitz in 2004, less than one year before it filed for bankruptcy protection (dismissed with prejudice, 474 F. Supp. 2d 505 (S.D.N.Y. 2007), aff’d, 2008 WL 2566557 (2d Cir. 2008));
- Representation of Renaissance Technologies as plaintiff in an action against two former employees and a hedge fund that employed them, asserting claims for trade secret theft and breach of confidentiality agreements;
- Defense of AWB Limited in four separate cases involving alleged improper payments to the Saddam Hussein regime in Iraq in connection with sales of wheat to Iraq through the United Nations Oil‑for‑Food‑Programme. The cases, which involved antitrust, civil RICO, FCPA, Alien Tort Statute and Torture Victim Protection Act claims, were all dismissed at the motion to dismiss stage (544 F. Supp. 2d 236 (S.D.N.Y. 2008); 2008 WL 4450265 (S.D.N.Y. 2008), aff’d, 2009 WL 3161363 (2d Cir. 2009); 2008 WL 4378443 (S.D.N.Y. 2008); 2013 WL 441959 (S.D.N.Y. 2013));
- Representation of JPMorgan as plaintiff and defendant in litigation against Korean investors relating to over $500 million of contested obligations under complex derivative contracts related to the collapse of Asian currencies in 1997 (see 269 F. Supp. 2d 424 (S.D.N.Y. 2003));
- Defense of Salomon Smith Barney in an action brought by a hedge fund seeking over $200 million in damages sustained in the bond market turmoil following the collapse of Long Term Capital Management in 1998 (summary judgment granted in favor of defendant, No. C‑601396/99 (N.Y. Sup. Ct. 2003), aff’d, 11 A.D.3d 218 (1st Dep’t 2004));
- Defense of two former directors of Transkaryotic Therapies, Inc. in a Delaware Chancery Court action brought by a group of hedge funds alleging that the directors breached their fiduciary duties by approving and recommending the 2005 acquisition of Transkaryotic by Shire Pharmaceuticals (summary judgment granted in favor of defendants, 2008 WL 2462767 (Del. Ch. June 19, 2008));
- Defense of Sun International Hotels Limited, Solomon Kerzner and Merv Griffin in a securities fraud class action involving claims under both the 1933 and 1934 Acts (summary judgment granted in favor of defendants, 1999 WL 191540 (S.D.N.Y. Apr. 6, 1999), aff’d, 201 F.3d 431 (2d Cir. 1999));
- Defense of Con Edison in a Federal securities class action arising out of the proposed merger of Con Ed and Northeast Utilities;
- Defense of DLJ in Federal and state court litigation brought by institutional investors relating to sales of high‑yield bonds underwritten by DLJ whose issuer went into bankruptcy;
- Defense of Hachette‑Filipacchi Magazines in an antitrust class action against major magazine publishers;
- Defense of Salomon Inc. and Salomon Brothers Inc. in Federal antitrust and securities class actions arising out of the 1991 Treasury auction scandal;
- Defense of Ciba Geigy Limited (now a part of Novartis) in a securities class action alleging violation of SEC Rule 14d‑10; and
- Representation of the trustee for the holder of $2.25 billion in defaulted municipal bonds, prosecuting Federal securities fraud claims against nearly 100 municipalities and public utilities that had guaranteed the bonds, in the WPPSS Securities Litigation, then the largest and most complex securities class action in history.
Mr. Baron was named a Leading Trial Lawyer by The Legal 500 in 2012 and has been recognized by that publication for his work in securities litigation, financial services litigation, mergers and acquisitions litigation, trade secrets litigation and appeals. From 2007 through 2012, Mr. Baron was cited as one of the country’s leading practitioners in securities and general commercial litigation by Chambers USA: America’s Leading Lawyers for Business. Mr. Baron was named a “National Star” for his securities work and was named a “Local Litigation Star” in the New York area by Benchmark Litigation from 2008 through 2013. The Best Lawyers in America named Mr. Baron a leader in commercial litigation from 2009 through 2013 and as a leader in antitrust, mergers and acquisitions and securities litigation from 2011 through 2013. Mr. Baron was also named to Lawdragon’s list of 500 Leading Lawyers in America from 2007 through 2012 and to its list of 100 Lawyers You Need to Know in Securities Litigation in 2008.
Mr. Baron received an A.B. cum laude from Princeton University in 1978 and his J.D. cum laude from Harvard Law School in 1981. Mr. Baron joined Cravath in 1981 and became a partner in 1988. Mr. Baron has served as Managing Partner of the Litigation Department since September 2010.
Mr. Baron may be reached by phone at 212‑474‑1422 or by email at firstname.lastname@example.org.